ClinicalTrials.gg
Active, not recruitingNCT04093310BARTHO-KTUpdated Jun 6, 2023

Cost-utility Analysis Treatment of Bartholin's Abscess : Word Catheter Versus Incision-drainage.

An interventional study of Word Catheter and Incision-drainage in Bartholin's Gland Abscess Treatment, sponsored by Nantes University Hospital. Active, not recruiting at 17 sites in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-06.

Sponsored by Nantes University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2024, 2 years 5 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
302
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Bartholin's gland abscess is a condition requiring emergency consultation. Placement of a Word catheter, which is a minor technique used in France as a treatment of bartholin's Abscess, can be done in an emergency room without hospitalization. Actually, incision-drainage, which is the most widespread treatment in France, is performed on day surgery with or without overnight hospitalization. Our hypothesis is that the use of Word catheter compared to incision-drainage would not modify the quality of life of the patients but would allow a saving of up to 3 M€ per year in France.

02

Conditions studied

  • Bartholin's Gland Abscess Treatment

Browse trials for

Keywords

  • incision-drainage
  • Bartholin's abscess
  • Word catheter
  • Marsupialization
  • Cost-utility analysis
03

In context

Abscess

152 studies on the registry are indexed under Abscess; 22 are open to participants now.

This study's enrollment of 302 is above the median of 110 across 120 interventional studies indexed under Abscess.

Browse Abscess studies →

Lead sponsor

Nantes University Hospital is the lead sponsor of 839 studies on the registry; 195 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Abscess of Bartholin's gland Patient able to understand the protocol Patient who signed Patient with social insurance

Exclusion criteria

Exclusion Criteria:

Spontaneous fistulization of the abscess before surgical treatment Abscess volume under 3 ml Medical treatment which avoid incision or word catheter placement patients under guardianship Unable to complete questionnaires Patients not affiliated to social protection regimen Pregnant or post-partum women (until 4 weeks after delivery)

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
302 participants (actual)

Study arms

  • Experimental
    Word catheter

    The abscess is incised and the Word catheter is inserted into the residual cavity to create a neo-channel to prevent recurrence. The catheter is removed after 4 weeks during a consultation

    Device: Word Catheter

  • Active comparator
    Incision-drainage

    This procedure performed under general or loco-regional anaesthesia consists in incising the abscess, draining the pus build-up and placing a wick in the residual cavity to promote progressive healing from the inside out.

    Procedure: Incision-drainage

Interventions

  • DeviceWord Catheter

    Use of the Word catheter to remove the Bartholin's abscess

  • ProcedureIncision-drainage

    Incision-drainage to remove the Bartholin's abscess

06

What researchers measure

Primary outcomes

  1. cost-utility ratio, according to the societal perspective of the of the management of Bartholin's gland abscess by the Word catheter compared to the incision-drainage

    The utility will be measured by: Quality Adjusted Life Year (QALYs) as estimated from responses to the Euroqol-5 Dimensions (EQ-5D 5L) health-related quality of life questionnaire. The questionnaire focuses on 5 dimensions: mobility, personal autonomy, current activities, pain/discomfort and anxiety/depression. For each of these dimensions, 5 answers are possible. The costs will be measured by the addition of the following costs: Outpatient resource consumption collected in a declarative patient questionnaire. Hospital care resources using the the database of the Medicalised Information System Program of each recruiting site

    Time frame: 12 months

Secondary outcomes

  1. Budget impact analysis for the health insurance point of view in case of diffusion of the Word catheter

    Comparison of intervention costs on the study sample and projection of these costs over 5 years, from the health insurance and hospital perspectives

    Time frame: 5 years

  2. Non inferiority evaluation of Word catheter vs. Incision drainage in terms of pain

    Pain numeric scale from 0 to 10

    Time frame: at baseline and day 1

  3. Non inferiority evaluation of Word catheter versus incision-drainage in terms of recurrence rate

    Number of homolateral recurrences of Bartholin's abscess, declared by the patient

    Time frame: 12 months

  4. Comparison of Word catheter versus incision-drainage concerning pain

    Pain numeric scale from 0 to 10

    Time frame: 12 months

  5. Comparison of Word catheter versus incision-drainage concerning management time

    Date and time of patient initial management (randomization) Date and time of the beginning of the procedure date and time of the end of the procedure date and time of the hospital departure

    Time frame: Day 0 (procedure day), Day 1

  6. Comparison of Word catheter versus incision-drainage in terms of complications

    number of complications related to the procedure (healing complications, infection, lost of the Word catheter), contro-lateral Bartholin's abscess occurrence

    Time frame: 12 months

  7. Comparison of Word catheter versus incision-drainage in terms of surgical failure

    Word catheter: insertion failure, loss, removal decision (from the patient or the surgeon) Incision-drainage: incomplete drainage

    Time frame: Immediate post-operative (D0) and one month

  8. Comparison of Word catheter versus incision-drainage in terms of impact on sexual activity

    Score of the Female Sexual Function Index: self-questionnaire including 19 questions assessing different parameters of the sexual activity

    Time frame: Baseline, one month, 6 months and 12 months

  9. Comparison of Word catheter versus incision-drainage in terms of quality of life using the SF-12-HS

    Short-Form-12-Health-Survey questionnaire score: self-questionnaire including 12 questions measuring different aspects of quality of life

    Time frame: Baseline, one month, 6 months and 12 months

  10. Comparison of Word catheter versus incision-drainage in terms of quality of life using the EQ-5D

    EQ-5D 5L score (described in primary outcome)

    Time frame: Baseline, one day, one month, 3 months, 6 months, 9 months and 12 months

  11. Comparison of Word catheter versus incision-drainage in terms global patient impression and improvement

    Patient Global Impression and Improvement (PGI-I) global index used to rate the response of a condition to a therapy (transition scale). It is a single question asking the patient to rate their global condition now, as compared with how it was prior to before beginning treatment on a scale from 1 - very much better to 7 - very much worse

    Time frame: One day, one month, 3 months, 6 months, 9 months and 12 months

07

Study locations

17 sites
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2020 (actual). Primary completion is estimated for May 2024, 52 months after the start.

Of 21 interventional studies with no phase under Abscess, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 56. This study's planned 52 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 16, 2019
First posted
Sep 18, 2019
StartActual
Jan 17, 2020
Primary completionEst.
May 31, 2024
CompletionEst.
May 31, 2024
Last update
Jun 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04093310
Responsible party
Sponsor
First posted
Sep 18, 2019
Start date
Jan 17, 2020
Primary completion
May 31, 2024 (estimated)
Completion
May 31, 2024 (estimated)
Last update
Jun 6, 2023

Study contacts

Thibault Thubert, PhD
principal investigator · Nantes University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion